Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells
from the side effects of chemotherapy.
PURPOSE: Phase IV trial to study the effectiveness of amifostine in treating patients with
cancer who have neurological changes caused by chemotherapy.